Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03965754 · ClinicalTrials.gov registry record
Assessing the Impact of myHealth Rewards Enrollment Emails
A clinical trial, sponsored by Geisinger Clinic.
- Completed
- Registry status
- 5,697
- Enrollment target
NCT03965754: Completed study, sponsored by Geisinger Clinic.
NCT03965754 is a clinical trial that has completed, run by Geisinger Clinic. The registered enrollment target is 5,697 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03965754 has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- 5,697 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate, prospectively, the potential impact of different email message conditions (no email, standard promotional email, social norms, and loss framing) on enrollment in a wellness program (myHealth Rewards) by Geisinger Health Plan (GHP) members.
Primary Outcome
Enrollment in the myHealth Rewards program (yes/no) within 7 full days of the beginning of the intervention (i.e., when the emails are first sent).
Interventions
- BEHAVIORAL Social norms
- BEHAVIORAL Loss framing
- BEHAVIORAL Email reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,697 participants |
| Start Date | 2019-05-07 |
| Est. Completion | 2019-05-14 |
What the finished NCT03965754 record still lists
NCT03965754 is an observational study that tracks outcomes without assigning an intervention. Its 5,697 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which Social norms is the first listed.
NCT03965754 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03965754 about?
NCT03965754 is a clinical study titled "Assessing the Impact of myHealth Rewards Enrollment Emails". The purpose of the study is to evaluate, prospectively, the potential impact of different email message conditions (no email, standard promotional email, social norms, and loss framing) on enrollment in a wellness program (myHealth Rewards) by Geisinger Health Plan (GHP) members.
What is the current status of trial NCT03965754?
This trial is currently completed. The enrollment target is 5,697 participants. The study started on 2019-05-07. Estimated completion is 2019-05-14.
What interventions are being tested in trial NCT03965754?
The interventions under investigation include: Social norms (BEHAVIORAL), Loss framing (BEHAVIORAL), Email reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT03965754?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04983875 · 5,708 participants · NA
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
- NCT06627335 · 5,621 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- NCT05636176 · 5,600 participants · Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
- NCT06981598 · 5,586 participants · NA
Prevention of Psychological Health Problems Via Integrated Operational Support
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI